Our news

Read through our press releases to follow Signifierʼs latest
news and updates

eXciteOSA Device and SmartPhone

Signifier Medical Technologies’ eXciteOSA®, the only FDA-authorized daytime therapy for primary snoring and mild obstructive sleep apnea, demonstrates real-world adherence to treatment of over 80%

21st September 2022

Signifier Medical Technologies Announces $49MM Purchase of Existing Shares

22nd March 2022

Signifier Medical Technologies is granted HCPCS Codes for eXciteOSA

22nd February 2022

Signifier Medical Technologies Raises $35M in Series D Funding Round

27th July 2021

New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA® Device

9th February 2021

IDEA Design Award 2020 for the World’s First, Daytime Treatment Device Tackling the Root Cause of Sleep-Disordered Breathing

17th September 2020

Global Webinar on: “Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea”

4th September 2020

Webinar on Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea

30th July 2020

Global Webinar on: “Latest Advances in the Management of Sleep Disordered Breathing”

17th July 2020

Webinar on Precision Medicine for Obstructive Sleep Apnea and Emerging Technologies

9th June 2020

Webinar on eXciteOSA®: Novel Approach to Treatment of Snoring and Mild OSA

19th May 2020

Webinar on Latest Advances in the Management of Sleep Disordered Breathing

20th April 2020

Signifier Medical Technologies Wins iF Design Award 2020 for Design Excellence for eXciteOSA®

25th February 2020